Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 32706 participants.

Also called NCT05932472

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 32,706 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05932472
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05932472. Randomized; no masking; primary purpose treatment. Start 2024-01-15 (actual); primary completion 2027-01-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
Acronym
ASPIRIN-C3
Condition
Atherosclerosis
Condition
Cardiovascular Diseases
Condition
Drug Effect
Intervention (Drug)
Aspirin
Lead sponsor
Tor Biering-Sørensen (class: other)

Record details

Record id
cardio:ct-nct05932472
Content hash
d87b70111127edc03b0900b6edcb5ee033feb2ddf15c637f2094654d66fc13c2